Literature DB >> 12067010

High-frequency oscillation in adolescents.

S Moganasundram1, A Durward, S M Tibby, I A Murdoch.   

Abstract

BACKGROUND: High-frequency oscillation (HFO) is a widely used lung-protective ventilatory strategy in paediatric and neonatal acute lung injury. Its safe and effective use has been hindered by inadequate recruitment of the lung during oscillation and, until recently, the lack of an adequately powered oscillator for use in adult practice.
METHODS: We present data from three adolescents with severe acute respiratory distress syndrome (ARDS) who received HFO with the Sensormedics 3100B oscillator after failure of conventional mechanical ventilation. A manual recruitment manoeuvre was used in all patients prior to mechanical ventilation (conventional or HFO) and following tracheal suctioning or disconnection from the ventilator. Changes in oxygenation index were used to assess therapy.
RESULTS: All patients showed at least a 25% reduction in oxygenation index within 2 h of HFO, with return to conventional ventilation after 27-65 h.
CONCLUSIONS: We found HFO, in conjunction with manual recruitment and prone positioning, to be a well-tolerated mode of ventilation in adolescents with ARDS and who were unresponsive to conventional ventilation. Given this success we hope to renew interest in this method for adults with ARDS, together with concurrent use of manual recruitment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067010     DOI: 10.1093/bja/88.5.708

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  Numerical study of high-frequency oscillatory air flow and convective mixing in a CT-based human airway model.

Authors:  Jiwoong Choi; Guohua Xia; Merryn H Tawhai; Eric A Hoffman; Ching-Long Lin
Journal:  Ann Biomed Eng       Date:  2010-07-08       Impact factor: 3.934

Review 2.  Acute lung injury and acute respiratory distress syndrome.

Authors:  Anil Vasudevan; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.